Back to Citadel Advisors LLC Citadel Advisors LLC

UTHR

Showing 8 of 31 quarters

Position history for Citadel Advisors LLCCitadel Advisors LLC's holdings in United Therapeutics Corporation

Yes. Citadel Advisors holds 928,464 shares of UTHR (United Therapeutics), worth $503.1M, as of its Q3 2026 13F filing. It increased the position from 304,692 shares in Q2 2026. Citadel Advisors has held UTHR since Q4 2024, across 8 quarterly 13F filings. UTHR is 0.1% of Citadel Advisors' reported 13F portfolio.

Current Value

$503.1M

Current Shares

928,464

Total Value Change

+$495.9M

Total Shares Change

+908,126

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
928,464
+204.7%
$503.1M0.1%$541.89
51
2026-Q2
Decreased
304,692
-15.5%
$165.1M0.0%$541.83
0
2026-Q1
Increased
360,643
+92.7%
$213.9M0.0%$592.98
49
2025-Q4
Decreased
187,164
-31.7%
$91.2M0.0%$487.25
0
2025-Q3
Increased
273,982
+94.3%
$114.9M0.0%$419.21
48
2025-Q2
Increased
141,011
+289.7%
$40.5M0.0%$287.35
47
2025-Q1
Increased
36,184
+77.9%
$11.2M0.0%$308.27
42
2024-Q4
New
20,338
-
$7.2M0.0%$352.84
38

Other major holders of UTHR: BlackRock, Inc.

Optional analytics helps us improve. How it’s used